A Study to Evaluate the Effects of LCI699 on Cortisol in Participants With Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

January 14, 2009

Primary Completion Date

August 12, 2009

Study Completion Date

August 12, 2009

Conditions
Hypertension
Interventions
DRUG

LCI699-matching placebo

LCI699-matching placebo oral capsules

DRUG

LCI699

LCI699 oral capsules

Trial Locations (11)

16684

Tipton Medical & Diagnostic Center, Tipton

28645

Northstate Clinical Research, Lenoir

28801

Clinical Study Center of Asheville, LLC, Asheville

75006

Punzi Medical Center, Carrollton

78229

dgd Research, Inc, San Antonio

80120

Metro Clinical Research, Littleton

90211

Impact Clinical Trials, Beverly Hills

90620

Associated Pharmaceutical Research Center, Inc, Buena Park

90710

Innovative Clinical Research, Inc, Harbor City

90806

Long Beach Center for Clinical Research, Long Beach

Unknown

Encode Clinic, Reykjavik

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Great Lakes Drug Development, Inc.

INDUSTRY

collaborator

Integrium

INDUSTRY

lead

Novartis

INDUSTRY